|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.2 HKD | +1.97% |
|
+11.51% | -17.55% |
| Apr. 22 | 3Sbio Inc. Announces Management Changes | CI |
| Apr. 15 | 3SBIO Gets China Nod for Use of Cancer Injection in Children with Thrombocytopenia | MT |
3SBio Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 7,815.94 million compared to CNY 6,865.74 million a year ago. Net income was CNY 1,549.24 million compared to CNY 1,915.73 million a year ago.
Basic earnings per share from continuing operations was CNY 0.64 compared to CNY 0.78 a year ago. Diluted earnings per share from continuing operations was CNY 0.62 compared to CNY 0.74 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.55% | 1.85B | |
| -4.06% | 86.13B | |
| +1.97% | 39.82B | |
| +56.59% | 25.23B | |
| -14.44% | 15.36B | |
| -8.82% | 11.95B | |
| -16.17% | 11.6B | |
| -41.58% | 11.51B | |
| +6.14% | 8.71B | |
| -7.02% | 8.12B |
3SBIO INC. 
